YOOZ Launches Comprehensive Laboratory to Meet New E-Cigarette Regulations

Aug.10.2022
YOOZ Launches Comprehensive Laboratory to Meet New E-Cigarette Regulations
YOOZ builds a comprehensive lab to promote research and innovation for electronic cigarettes, prioritizing quality and safety.

Starting from May 1, 2022, the mandatory national standard for electronic cigarettes was approved by the State Administration for Market Regulation and the National Standardization Management Committee. The "Regulations on the Management of Electronic Cigarettes" issued by the State Tobacco Monopoly Administration will also come into effect. The orderly implementation of the national standard and regulations not only marks the formal entry of the electronic cigarette industry into a phase with legal compliance, but also serves as a driving force for guiding electronic cigarette companies to gradually develop in the direction of scientific research and innovation. In order to better implement regulatory requirements and promote comprehensive innovation in the industry through scientific and technological innovation, YOOZ, a leading electronic cigarette company, has recently publicly launched a comprehensive laboratory built around CNAS standards.


In response, YOOZ, a department related to the company, stated that the implementation of both the national standard for electronic cigarettes and the new regulations is a boost for the long-term development of the industry. YOOZ has consistently relied on scientific research to support a more sustainable industry development strategy. This is both a responsibility and a necessary attitude for electronic cigarette companies to maintain a stable development trajectory.


With meticulous analysis, we always adhere to the principle of "customer first.


As we all know, consumers' greatest concerns always revolve around product quality and safety. Electronic cigarettes, which are often thought to have a low technological threshold, are at risk of having their quality and safety overlooked. However, the lower the technological threshold of a product, the greater the need for safety production and compliance. Prior to regulations being enforced, the electronic cigarette market was filled with various generic and fake products. Guarding consumer safety has become one of the crucial issues in the development of the industry. As a leading enterprise in the industry, YOOZ has always upheld the principle of "putting users first" and continuously strives to protect consumer rights.


Although e-cigarettes are often mocked as low-tech products, every production process and component must go through a rigorous and safe production process to prevent products with quality defects from entering the market. YOOZ's laboratory took half a year to prepare and put into use, and was built in accordance with CNAS standards. The testing center mainly consists of a physical laboratory, a chemical laboratory, an electrical laboratory, and an environmental laboratory, with more than 70 instruments and the ability to conduct over 100 standardized tests. YOOZ has a standardized testing method and strict quality management system in place for quality control and testing, thoroughly evaluating product performance, reliability, and safety throughout the product development process.


YOOZ Citrus Detection Center has developed simulated artificial smoking detection devices that mimic users' daily habits to provide more accurate experiences. Additionally, these devices help the company develop products that meet the needs of different users and provide more options. In addition, the batteries used in YOOZ products undergo over 400 cycles of charge and discharge in a longevity laboratory, as well as safety performance testing under various extreme conditions. This ensures that the product has good performance when frequently used by users.


It is noteworthy that the YOOZ Lemon Lab has taken the initiative to add a waterproof test in accordance with the National Standard for Electronic Cigarettes and the Measures for the Administration of Electronic Cigarettes. This demonstrates YOOZ Lemon's determination and implementation speed in compliance development, as well as their effort to improve and meet national standard requirements.


Moving towards research-oriented businesses is the development goal and mission of electronic cigarette companies.


YOOZ Laboratory not only bears the responsibility of safety and innovation, but also serves as a central hub that connects and streamlines the upstream and downstream industries. For businesses, the laboratory takes control of both research and production standards, leading to a more selective and high-quality choice of suppliers through strict requirements. This stimulates the development of the supply chain by reversing the stimulating effect of R&D capabilities, resulting in the production of safer, more environmentally friendly, and more cost-effective products that fully satisfy consumers' needs.


In the future, YOOZ will continue to prioritize consumer satisfaction and aim for long-term growth. They will spare no effort in ensuring compliance, safety, scientific research, innovation, and environmental friendliness, serving as a model for industry leaders. They will actively recruit talent and use their technological capabilities to push forward the development of the electronic cigarette industry, bringing more value to the industry's progress.


This article contains excerpts or reprints of third-party information, and the copyright belongs to the original media and author. If there is any infringement, please contact us for deletion. Any unit or individual that needs to reprint, please contact the author and do not repost directly.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Philip Morris Italia Invests €1 Million to Upgrade Retail Network, Supporting 45,000 Tobacco Shops in Smoke-Free Shift
Philip Morris Italia Invests €1 Million to Upgrade Retail Network, Supporting 45,000 Tobacco Shops in Smoke-Free Shift
Philip Morris Italia has launched the Trade Academy program, investing €1 million to provide training and development support for approximately 45,000 tobacco retailers in Italy. The initiative aims to strengthen retailers’ capabilities in heated tobacco products, digital tools and consumer services. The move reflects how nicotine companies are increasingly investing in retail networks and frontline capabilities as new nicotine products become more important in the market.
Jul.28
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
The FDA authorized the JUUL2 device and tobacco- and menthol-flavored pods on Aug. 28, bringing the number of authorized e-cigarette products to 48. The agency highlighted complete switching among adult smokers, with six-week switching rates reaching 28.4%–49.3% for the menthol pod. The decision comes as FDA works to speed PMTA reviews, reduce application backlogs and expand authorized e-cigarette and nicotine-pouch products while maintaining enforcement priorities for unauthorized products.
Regulations
Aug.29
China’s HTP Exports Fell 14.3% in H1 2026 as Russia and Belarus Accounted for 76% Lead
China’s HTP Exports Fell 14.3% in H1 2026 as Russia and Belarus Accounted for 76% Lead
In H1 2026, China’s HS 24041100 exports stood at $1.32 million, down 14.3% YoY, with volume falling 17.2% to 55.33 tons. Market distribution shifted drastically amid overall export drops. Exports to Russia and Belarus totaled $1 million, taking 76.0% of all shipments versus 29.5% in H1 2025. Belarus became the top destination with export value jumping 177.5%, while the Philippines, Singapore and Indonesia’s combined share slumped from 49.3% to 11.2%.Domestically, Yunnan led exporter registrations; Jiangsu and Shanghai were key suppliers, yet Anhui and Sichuan had no exports. Heavy concentration means order or declaration changes for Russia/Belarus greatly affect national aggregate data. The data shows customs entry points (not end markets), covering tobacco consumables only, excluding heating equipment and the complete HTP supply chain.
Aug.11
Product | BAT Expands VELO Peach Ice Medium to FamilyMart Stores Nationwide in Japan
Product | BAT Expands VELO Peach Ice Medium to FamilyMart Stores Nationwide in Japan
British American Tobacco Japan (BAT Japan) expanded VELO Peach Ice Medium to FamilyMart stores nationwide in Japan from September 7, 2026. The oral tobacco product first launched on July 6 and had previously been sold through VELO's official online store, glo Store Ginza and tobacco retailers. It combines peach flavor with menthol cooling at a Medium strength level and is priced at JPY 360. Japanese tobacco retailers list 15 pouches per pack. The move adds the new SKU to an existing nationwide FamilyMart distribution network for VELO rather than marking the brand's first entry into the convenience-store chain.
Sep.15
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
Less than a week after JUUL2 received U.S. FDA marketing authorization on August 28, 2026, JUUL Labs was sued for patent infringement in federal court in Delaware. AJ Marketing LLC filed the complaint on September 3, alleging that both JUUL 1 and JUUL2 infringe U.S. Patent No. 8,851,068 B2. The patent covers aspects of programmable electronic vaporization devices, including controls over dose delivery, usage frequency and operating parameters. The plaintiff is seeking reasonable royalties and ongoing royalties tied to the remaining life of the patent. JUUL has not yet publicly responded to the case.
Sep.10
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
The U.S. Food and Drug Administration authorized 11 ZYN ULTRA nicotine pouch products made by Swedish Match USA through the premarket tobacco product application pathway on August 21, 2026. Ten of the authorized products have a labeled nicotine content of 9 mg, while ZYN ULTRA Smooth was authorized at 11 mg. The reviews were conducted through FDA’s nicotine pouch PMTA pilot program. FDA has now authorized 43 nicotine pouch products, including 23 through the pilot.
Aug.24